CERo Therapeutics Holdings, Inc.
CERO
$0.01
$0.00-9.91%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -86.31% | -139.87% | -43.61% | -87.54% | -55.37% |
| Total Depreciation and Amortization | -4.54% | -6.64% | -5.93% | -2.49% | 1.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.05% | 125.74% | 45.39% | 48.10% | -109.07% |
| Change in Net Operating Assets | -82.15% | -89.70% | 184.83% | 516.00% | 359.82% |
| Cash from Operations | -17.21% | -24.50% | -11.97% | -22.68% | -30.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 103.62% | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | 63.29% | -49.82% | -1,943.15% |
| Issuance of Common Stock | -9.28% | -28.21% | -31.68% | 15.57% | -24.66% |
| Repurchase of Common Stock | 78.77% | 78.77% | 78.77% | -- | -238,368.42% |
| Issuance of Preferred Stock | -47.15% | -39.06% | -51.70% | -62.95% | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -127.59% | 646.33% | 836.70% | 22,943.07% | 7,795.63% |
| Cash from Financing | -25.93% | 1.37% | -2.33% | 33.58% | 66.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -811.89% | -305.09% | -1,314.69% | 70.00% | 135.72% |